CSI Market
Sign In | Register

Ligand Pharmaceuticals Incorporated (LGND) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access LGND Annual Balance Sheets →
Balance sheet patterns shown here provide context for understanding Ligand Pharmaceuticals Incorporated's financial stability and long-term positioning.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent55.96
Restricted Cash51.55
Short-term Investments, Total318.35
Cash & Short-term Investments373.00
Accounts receivable83.22
Income Taxes Receivable, Current NO24.30
Inventories14.51
Derivative Asset, Current DE30.97
Other Current Assets0.00
Total Current Assets608.23
Equipment/Property/Plant Net3.71
Goodwill net207.86
Intangible Assets509.90
Long-term investments94.48
Derivative Asset, Noncurrent DE129.20
Other Assets, Noncurrent784.08
Total Assets2,237.46
Liabilities
Accounts Payable, Current AC4.10
Accrued Liabilities, Current AC35.67
Derivative Liability, Current DE0.28
Convertible Debt, Current LO448.31
Other Liabilities, Current9.48
Taxes Payable, Current, Total2.75
Total Current Liabilities500.57
Long-term debt1,128.22
Total Long-term Debt1,128.22
Other liabilities, Noncurrent0.00
Current Portion Of Liability For Contingent Value Rights0.28
Liability For Contingent Value Rights3.50
Total Liabilities1,275.70
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock403.54
Retained Earnings / Accumulated Deficit554.77
Accumulated Other Comprehensive Income3.44
Other Equity3.44
Common Stockholder's Equity961.76
Total Stockholder's Equity961.76
Liabilities & Stockholder's Equity2,237.46
4 historic quarters locked

Sign in to unlock the full Ligand Pharmaceuticals Incorporated balance sheet history.

Sign In Create Free Account

About Ligand Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000886163-26-000060

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI